摘要
肺孢子菌肺炎(PCP)是由人耶氏肺孢子菌引起的呼吸系统严重机会感染。认识PCP在儿童移植受者和肿瘤患者中的危险因素和临床表现,了解其预防适应证和治疗方案,对促进早诊断和降低患病风险至关重要。考虑这一复杂的患者群体经常面临的具体挑战,该文对PCP防治进展进行综述。
Pneumocystis pneumonia(PCP)is a severe opportunistic respiratory infection caused by human Pneumocystis jiroveci.Understanding the risk factors and clinical manifestations of PCP in pediatric transplant recipients and cancer patients,and understanding the indications for prevention and treatment regimens,are critical to promoting early diagnosis and reducing the risk of PCP.In view of the specific challenges that this complex patient population often face,we review the progress of the prevention and treatment of PCP in this paper.
作者
代艳
李新叶
唐慧荷
孙会静
梁亮
温志红
DAI Yan;LI Xin-ye;TANG Hui-he(Department of Paediatrics, the People′s Hospital of Guangxi Zhuang Autonomous Region, Nanning 530021, China)
出处
《中国临床新医学》
2021年第2期134-138,共5页
CHINESE JOURNAL OF NEW CLINICAL MEDICINE
基金
广西卫健委科研课题(编号:Z20170360)。
关键词
肺孢子菌肺炎
儿童
血液病
移植
肿瘤
免疫功能不全
预防
治疗
Pneumocystis pneumonia(PCP)
Children
Blood disease
Transplantation
Tumor
Immunodeficiency
Prevention
Treatment
